MoneyWorks4Me

The revenue for the September 2025 quarter is pegged at Rs. 17571.50 millions, about 7.62% up against Rs. 16326.70 millions recorded during the year-ago period.Net profit stood at Rs. 4152.70  millions  compared to Rs. 3586.10 millions in the corresponding previous quarter,high by 15.80%.Operating profit surged to 5721.20 millions from the corresponding previous quarter of 4994.40 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 17571.50 16326.70 7.62 34955.00 31902.80 9.57 64091.50 58489.10 9.58
Other Income 699.50 604.80 15.66 1427.90 1278.10 11.72 2755.80 2482.70 11.00
PBIDT 5721.20 4994.40 14.55 10905.50 9577.80 13.86 19701.80 17013.70 15.80
Interest 75.50 25.00 202.00 133.70 52.50 154.67 114.30 124.50 -8.19
PBDT 5645.70 4969.40 13.61 10771.80 9525.30 13.09 19587.50 16889.20 15.98
Depreciation 186.40 175.10 6.45 381.20 358.80 6.24 718.00 711.70 0.89
PBT 5459.30 4794.30 13.87 10390.60 9166.50 13.35 18869.50 16177.50 16.64
TAX 1306.60 1208.20 8.14 2579.30 2300.30 12.13 4725.10 4165.30 13.44
Deferred Tax -10.00 -2.10 376.19 -15.00 -23.70 -36.71 27.20 10.70 154.21
PAT 4152.70 3586.10 15.80 7811.30 6866.20 13.76 14144.40 12012.20 17.75
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 32.56 30.59 6.44 31.20 30.02 3.92 30.74 29.09 5.68
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..